Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.
Bashey, Asad
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older. [electronic resource] - Leukemia research Apr 2006 - 503-6 p. digital
Publication Type: Journal Article
0145-2126
10.1016/j.leukres.2005.09.002 doi
Acute Disease
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cytarabine--administration & dosage
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Leukemia, Myeloid--drug therapy
Middle Aged
Remission Induction
Vidarabine--administration & dosage
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older. [electronic resource] - Leukemia research Apr 2006 - 503-6 p. digital
Publication Type: Journal Article
0145-2126
10.1016/j.leukres.2005.09.002 doi
Acute Disease
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cytarabine--administration & dosage
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Leukemia, Myeloid--drug therapy
Middle Aged
Remission Induction
Vidarabine--administration & dosage